South Plainfield, NJ -- October 10, 2013 -- GENEWIZ, Inc. leading global genomic service provider, will join the ISBioTech First Fall Meeting next week in Rosslyn, Virginia, with a featured presentation by Dr. Jeffrey A. Shaman, Business Development Lead, Translational Genomics.
Speaking about detection and identification of cell and virus bank contamination, Dr. Shaman will discuss relevant concerns and challenges presented by biopharmaceutical banks. He will further review study data suggesting that next generation sequencing technologies provide broad range, sensitive, and long-lasting information for application within larger safety monitoring programs, during the featured presentation, ‘What's in My Bank? Approaches to Adventitious Virus, Microbial, and Cell Line Testing.’
With the Ion Proton™, GENEWIZ can deliver exome sequencing and RNA-Seq projects rapidly and cost-effectively, without the requirement of multiplexing large numbers of samples per run.
As a full-service next generation sequencing provider, GENEWIZ offers small genome sequencing services for research and discovery of microbes and viruses, as well as for biologics testing in a GLP-compliant regulatory environment. GENEWIZ also provides adventitious agent contamination testing solutions for the detection and identification of virus, microbial, and host and feeder cell contaminants in cell lines. In conjunction with other methods, NGS-based contamination testing provides a highly sensitive solution to established biosafety programs, such validation of biopharmaceuticals and biosimilars, and characterization of virus banks, virus vaccines, and cell banks.
Highlighting two programs, Cell Line Development & Banking, and Rapid Scale-Up & Testing, the ISBioTech Fall Meeting is designed to share the techniques and best practices needed to establish stable and well-characterized cell banks, as well as the processes and testing methods for rapid scale-up of clinical trial materials and licensed products.
About GENEWIZ, Inc.
GENEWIZ, Inc. is a global contract research organization (CRO) specializing in genomic services, including DNA sequencing, gene synthesis, molecular biology, genomic, bioinformatics, and GxP/CLIA regulatory-compliant services. GENEWIZ leads the industry in outsourcing partnerships with pharmaceutical, biotechnology, clinical, academic, and government institutions.
Headquartered in South Plainfield, NJ, GENEWIZ, Inc. is a privately-held global enterprise with locations in Boston, MA; Washington, DC Metro; Research Triangle Park, NC; San Diego, CA; San Francisco, CA; and Seattle, WA. International locations include Beijing, China; Suzhou, China; London, United Kingdom; and Tokyo, Japan.